Understanding OUR Cytokine-Based Immunotherapy Candidates Our determination extends to advancing a robust portfolio of programs aimed toward expanding the horizons of cytokine-based immunotherapy, specifically for cancers where treatment possibilities remain limited. Utilize the links below to learn additional about our portfolio of cytokine-based immunotherapy candidates. Discover Ou... https://financefeeds.com/xs-com-appoints-stelios-pallis-as-chief-technology-officer/